Evaluation of a collagen cell carrier for urethral reconstructive surgery using a biological simulation model by S. Aufderklamm, A. Stenzl, B. Amend

Get full text

Reconstructive urology by K.D. Sievert, B. Winter, A. Stenzl

Get full text

KEYNOTE-641 phase 3 study of pembrolizumab plus enzalutamide versus placebo plus enzalutamide for metastatic castration-resistant prostate cancer by A. Stenzl, J. Burgents, L.W. Liang, J.N. Graff

Get full text

Cytology-based photodynamic detection of bladder cancer cells in voided urine by Y. Nakai, S. Aufderklamm, N. Harland, J. Johaenning, K. Fujimoto, Y. Hirao, A. Stenzl

Get full text

Immunological markers and somatic mutations as predictors for therapy selection in metastatic renal cell carcinoma by J. Bedke, L. Herrmann, V. Stühler, S. Winter, A. Reustle, A. Stenzl, E. Schaeffeler, M. Schwab

Get full text

Expression of immune checkpoint ligand CD276 (B7-H3) is regulated in urothelial carcinoma on a transcriptional and post-transcriptional level and drops significantly in late stage... by W. Aicher, F.B. Maurer, L. Reitnauer, M. Korn, M. Maas, J. Hennenlotter, T. Todenhöfer, A. Stenzl

Get full text

Laparoscopic radical nephrectomy with inferior vena cava thrombectomy: highlight of key surgical steps by A. Sim, T. Todenhöfer, J. Mischinger, O. Fahmy, J. Boettge, S. Rausch, S. Bier, S. Aufderklamm, A. Stenzl, G. Gakis, C. Schwentner

Get full text

Prostate cancer and diabetes mellitus - indications for an association between glucose metabolism and androgen receptor signalling by T. Todenhöfer, G.I. Russo, G. Morgia, G. Broggi, R. Caltabiano, J. Hennenlotter, U. Kühs, S.Z. Lutz, A. Stenzl, M. Heni

Get full text

Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy: a multicenter randomized, double-blind, placebo-controlled tria... by A Stenzl, H Penkoff, E Dajc-Sommerer, A Zumbraegel, L Hoeltl, M Scholz, C Riedl, J Bugelnig, A Hobisch, M Burger, G Mikuz, U Pichlmeier

Get full text

ARCHES: Efficacy of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC) by prior local and systemic... by A. Stenzl, R.Z. Szmulewitz, D. Petrylak, J. Holzbeierlein, A. Villers, A. Azad, A. Alcaraz, B. Alekseev, T. Iguchi, N.D. Shore, F. Gomez-Veiga, B. Rosbrook, B. Baron, G.P. Haas, A. Armstrong

Get full text